Antiphosphatidylserine antibodies and reproductive failure

Lupus

Volumn 13, Issue 9, 2004, Pages 661-665

  Blank, M ^a,b   Shoenfeld, Y ^a,b  

^a SHEBA MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Anti annexine; Anti beta 2 glycoprotein; Anti prothrombin; Antiphospholipid syndrome; Apoptosis; Autoimmunity; Fetal loss

Indexed keywords

ACTIN ANTIBODY; AUTOANTIBODY; BETA2 GLYCOPROTEIN 1 ANTIBODY; CARDIOLIPIN ANTIBODY; LAMININ 1; LIPOCORTIN 5; MITOCHONDRION ANTIBODY; PHOSPHATIDYLETHANOLAMINE; PHOSPHATIDYLSERINE; PHOSPHOLIPID BINDING PROTEIN; POLY(ADENOSINE DIPHOSPHATE RIBOSE); PROGESTERONE; PROLACTIN; PROTHROMBIN ANTIBODY; THROMBOPLASTIN; THYROGLOBULIN ANTIBODY;

ANTIBODY BLOOD LEVEL; ANTICOAGULATION; ANTIPHOSPHOLIPID SYNDROME; BINDING AFFINITY; CONFERENCE PAPER; FETUS DEATH; FETUS WASTAGE; HUMAN; MOLECULAR INTERACTION; NONHUMAN; PLACENTA INSUFFICIENCY; PRIORITY JOURNAL; RECURRENT ABORTION; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOSIS; TROPHOBLAST;

ABORTION, SPONTANEOUS; ANIMALS; ANTIPHOSPHOLIPID SYNDROME; AUTOANTIBODIES; FEMALE; FETAL DEATH; HUMANS; PHOSPHATIDYLSERINES; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY COMPLICATIONS, HEMATOLOGIC;

EID: 4644274193     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1191/0961203304lu1088oa     Document Type: Conference Paper

References (59)

1. Sims PJ, Wiedmer T. Unraveling the mysteries of phospholipid scrambling, Thromb Haemostasis 2001; 86: 266-275.
2. Manno S, Takakuwa Y, Mohandas N. Identification of a functional role for lipid asymmetry in biological membranes: phosphatidylserine-skeletal protein interactions modulate membrane stability. Proc Natl Acad Sci USA 2002; 99: 1943-1948.
3. Morrish DW, Dakour J, Li H. Life and death in the placenta: new peptides and genes regulating human syncytiotrophoblast and extravillous cytotrophoblast lineage formation and renewal. Curr Protein Pept Sci 2001; 2: 245-259.
4. Branch DW. Autoimmunity and pregnancy loss. JAMA 1990; 264: 1453-1454.
5. Cowchock S. Autoantibodies and pregnancy wastage. Am J Rep Imm 1991; 26: 38-41.
6. Rote NS, Vogt E, DeVere G, Obringer AR, Ng AK. The role of placental trophoblast in the pathophysiology of the antiphospholipid antibody syndrome. Am J Reprod Immunol 1998; 39: 125-136.
7. Levine JS, Branch DW, Rauch, J. The antiphospholipid syndrome. N Engl J Med 2002; 346: 752-763.
8. Oshiro BT, Silver RM, Scott JR, Yu H, Branch DW. Antiphospholipid antibodies and fetal death. Obstet Gynecol 1996; 87: 489-493.
9. Branch DW, Silver RM, Blackwell JL, Reading JC, Scott JR. Outcome of treated pregnancies in women with antiphospholipid syndrome: an update of the Utah experience. Obstet Gynecol 1992; 80: 614-620.
10. Faussett MB, Branch DW Autoimmunity and pregnancy loss. Semin Reprod Med 2000; 18: 379-392.
11. Clifford K, Rai R, Watson H, Regan L. An informative protocol for the investigation of recurrent miscarriage: preliminary experience of 500 consecutive cases. Hum Reprod 1994; 9: 1328-1332.
12. Yetman DL, Kutteh WH. Antiphospholipid antibody panels and recurrent pregnancy loss: prevalence of anticardiolipin antibodies compared with other antiphospholipid antibodies. Fertil Steril 1996; 66: 540-546.
13. Branch DW, Silver R, Pierangeli S, van Leeuwen I, Harris EN. Antiphospholipid antibodies other than lupus anticoagulant and anticardiolipin antibodies in women with recurrent pregnancy loss, fertile controls, and antiphospholipid syndrome. Obstet Gynecol 1997; 89: 549-555.
14. Harris EN, Gaharavi AE, Boey ML et al.. Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus. Lancet 1983; 2: 1211-1214.
15. Hughes GRV, Harris EN, AE Gharavi. The anti-cardiolipin syndrome. J Rheumatol 1986; 13: 486-489.
16. Asherson RA, Cervera R, Piette JC, Shoenfeld Y. Milestones in the antiphospholipid syndrome. In Asherson RA, Cervera R, Piette JC, Shoenfeld Y eds. The antiphospholipid syndrome. II - Autoimmune thrombosis. Amsterdam: Elsevier, 2002: 145-343.
17. Shoenfeld Y. Systemic antiphospholipid syndrome. Lupus 2003; 12: 497-498.
18. Khamashta MA, Hughes GRV Phospholipid antoantibodies - cardiolipin. In Peter JP, Shoenfeld Y eds. Autoantibodies. Amsterdam: Elsevier, 1996: 624-629.
19. De Wolf F, Carreras LO, Moerman P, Vermylen J, Van Assche A, Renaer M. Decidual vasculopathy and extensive placental infarction in a patient with repeated thromboembolic accidents, recurrent fetal loss, and a lupus anticoagulant. Am J Obstet Gynecol 1982; 142: 829-834.
20. Rand JH, Wu XX, Andree HAM et al. Pregnancy loss in the antiphospholipid-antibody syndrome - a possible thrombogenic mechanism. N Engl J Med 1997; 337: 154-160.
21. di Somone N, Meroni PL, del Papa N et al. Antiphospholipid antibodies affect trophoblast gonadotropin secretion and invasiveness by binding directly and through adhered beta2-glycoprotein I. Arthritis Rheum 2000; 43: 140-150.
22. McNeil HP, Chesterman CN, Krilis, SA. Immunological and clinical importance of anti-phospholipid antibodies. Adv Immunol 1991; 49: 193-280.
23. Matsubayashi H, Sugi T, Arai T et al. Different antiphospholipid antibody specificities are found in association with early repeated pregnancy loss versus recurrent IVF-failure patients. Am J Reprod Immunol 2001; 46: 323-329.
24. Sher G, Fisch JD, Maassarani G, Matzner W, Ching W, Chong P. Antibodies to phosphatidylethanolamine and phosphatidylserine are associated with increased natural killer cell activity in non-male factor infertility patients. Hum Reprod 2000; 15: 1932-1936.
25. Katsuragawa H, Rote NS, Inoue T, Narukawa S, Kanzaki H, Mori T. Monoclonal antiphosphatidylserine antibody reactivity against human first-trimester placental trophoblasts. Am J Obstet Gynecol 1995; 172: 1592-1597.
26. Rote NS, Stetzer BR Autoimmune disease as a cause of reproductive failure. Clin Lab Med 2003; 23: 265-293.
27. Vogt E, Lyden TW, Rote NS. Monoclonal antiphosphatidylserine antibody induces intrauterine growth retardation in BALB/c mice. Clin Exp Rheum 1992; 10: 641-645.
28. Blank M, Tincani A, Shoenfeld Y. Induction of antiphospholipid syndrome in naive mice with purified IgG anti-phosphatidylserine antibodies. J Rheumatol 1994; 21: 100-104.
29. Yodfat O, Blank M, Krause I, Shoenfeld Y. The pathogenic role of anti-phosphatidylserine antibodies: active immunization with the antibodies leads to the induction of antiphospholipid syndrome. Clin Immunol Immunopathol 1996; 78: 14-20.
30. Levy R, Nelson DM. To be, or not to be, that is the question. Apoptosis in human trophoblast. Placenta 2000; 21: 1-13.
31. Katsuragawa H, Kanzaki H, Inoue T, Hirano T, Mori T, Rote NS. Monoclonal antibody against phosphatidylserine inhibits in vitro human trophoblastic hormone production and invasion. Biol Reprod 1997; 56: 50-58.
32. Shurtz-Swirsky R, Jnbar O, Blank M et al. In vitro effect of anticardiolipin autoantibodies upon total and pulsatile placental hCG secretion during early pregnancy. Am J Reprod Immunol 1993; 29: 206-210.
33. Sugimura M, Kobayashi T, Shu F, Kanayama N, Terao T. Annexin V inhibits phosphatidylserine-induced intrauterine growth restriction in mice. Placenta 1999; 20: 555-560.
34. Vogt E, Ng AK, Rote NS. Antiphosphatidylserine antibody removes annexin-V and facilitates the binding of prothrombin at the surface of a choriocarcinoma model of trophoblast differentiation. Am J Obstet Gynecol 1997; 177: 964-972.
35. Matalon ST, Shoenfeld Y, Blank M, Yacobi S, von Landenberg P, Ornoy A. Antiphosphatidylserine antibodies affect rat yolk sacs in culture: a mechanism for fetal loss in antiphospholipid syndrome. Am J Reprod Immunol 2004; 51: 144-151.
36. Di Somone N, Meroni PL, de Papa N et al. Antiphospholipid antibodies affect trophoblast gonadotropin secretion and invasiveness by binding directly and through adhered beta 2 glycoprotein I. Arthritis Rheum 2000; 43: 140-150.
37. McIntyre JA. Antiphospholipid antibodies in implantation failures. Am J Reprod Immunol 2003; 49: 221-229.
38. Schwarzenbacher R, Zeth K, Diederichs K et al.. Crystal structure of human beta2-glycoprotein I: implications for phospholipid binding and the antiphospholipid syndrome. EMBO J 1999; 18: 6228-6239.
39. 2-glycoprotein I to phospholipids based on its crystal structure EMBO J 1999; 18: 5166-5174.
40. Brighton TA, Hogg PJ, Dai YP, Murray BH, Chong BH, Chesterman CN. Beta-2-glycoprotein I in thrombosis: evidence for a role as a natural anticoagulant. Br J Haematol 1996; 93; 185-194.
41. Koike T, Ichikawa K, Atsumi T, Kasahara H, Matsuura E. Beta 2-glycoprotein I-anti-beta 2-glycoprotein I interaction. J Autoimmun 2000; 15: 97-100.
42. Sheng Y, Kandiah DA, Krilis SA. Beta2-glycoprotein-I: target antigen for antiphospholipid antibodies. Immunological and molecular aspects. Lupus 1998; 7: 5-9.
43. Out HJ, Kooijman CD, Bruins HW, Derksen RHWM. Histo-pathological findings from patients with intrauterine fetal death and antiphospholipid antibodies. Eur J Obstet Gynecol 1991; 41: 179-186.
44. 2-glycoprotein-I) induces experimental APS in naive mice. J Autoimmun 1994; 7: 441-447.
45. Arvieux S, Darnige L, Caron C, Reber G, Bensa JC, Colomb MG. Development of an ELISA for autoantibodies to prothrombin showing their prevalence in patients with lupus anticoagulants. Thromb Haemost 1995; 74: 1120-1125.
46. Galli M, Barbui T. Antiprothrombin Abs: detection and clinical significance in the aPL syndrome. Blood 1999; 93: 2149-2157.
47. Falcon CR, Martinuzzo ME, Forastiero RR, Cerrato GS, Carreras LO. Pregnancy loss and autoantibodies against phospholipid-binding proteins. Obstet Gynecol 1997; 89: 975-980.
48. von Landenberg P, Matthias T, Zaech J et al. Antiprothrombin antibodies are associated with pregnancy loss in patients with the antiphospholipid syndrome. Am J Reprod Immunol 2003; 49: 51-56.
49. Tsutsumi A, Atsumi T, Yamada H et al. Anti-phosphatidylserine/prothrombin antibodies are not frequently found in patients with unexplained recurrent miscarriages. Am J Reprod Immunol 2001; 46: 242-244.
50. Rao LV, Hoang AD, Rapaport SI. Mechanism and effects of the binding of lupus anticoagulant IgG and prothrombin to surface phospholipid. Blood 1996; 88: 4173-4182.
51. Chukwuocha RU, Hsiao ET, Shaw P, Witztum JL, Chen PP. Isolation, characterization and sequence analysis of five IgG monoclonal anti-beta 2-glycoprotein-1 and anti-prothrombin antigen-binding fragments generated by phage display. J Immunol 1999; 163: 4604-4611.
52. Arai T, Matsubayashi H, Sugi T et al. Anti-annexin A5 antibodies in reproductive failures in relation to antiphospholipid antibodies and phosphatidylserine. Am J Reprod Immunol 2003; 50: 202-208.
53. Rand JH, Wu XX, Culler S et al. Reduction of annexin-V (placental anti-coagulant protein-I) on placental villi of women with aPL Abs and recurrent spontaneous abortion. Am J Obstet Gynecol 1994; 171: 1566-1572.
54. Rand JH, Wu XX. Antibody-mediated disruption of the annexin-V antithrombotic shield: a new mechanism for thrombosis in the aPL syndrome. Thromb Haemost 1999; 82: 649-655.
55. Rand JH, Wu XX, Quinn AS et al. Human monoclonal antiphospholipid antibodies disrupt the annexin A5 anticoagulant crystal shield on phospholipid bilayers: evidence from atomic force microscopy and functional assay. Am J Pathol 2003; 163: 1193-1200.
56. Matsubayashi H, Arai T, Izumi S, Sugi T, McIntyre JA, Makino T. Anti-annexin V antibodies in patients with early pregnancy loss or implantation failure. Fertil Steril 2001; 76: 694-699.
57. Krikun G, Lockwood CJ, Wu XX et al. The expression of the placental anticoagulant protein, Annexin-V, by villous trophoblasts: immunolocalization and in vitro regulation. Placenta 1994; 15: 601-612.
58. Nakamura N, Ban T, Yamaji K, Yoneda Y, Wada Y. Localization of the apoptosis-inducing activity of lupus anticoagulant in an annexinV-binding antibody subset. J Clin Invest 1998; 101: 1951-1959.
59. Di Simone Castellani R, Caliandro D, Caruso A. Monoclonal anti-annexin V antibody inhibits trophoblast gonadotropin secretion and induces syncytiotrophoblast apoptosis. Biol Reprod 2001; 65: 1766-1770.